Search Login Register

Hyperaldosteronism (Conn Syndrome) Summary

Description: A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.

Also Known As: Conn Syndrome; Aldosteronism; Syndrome, Conn; Conn's Syndrome; Primary Hyperaldosteronism Show All >>

Networked: 3019 relevant articles (126 outcomes, 240 trials/studies) for this Disease

Key Drugs and Agents for Hyperaldosteronism

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Aldosterone : 45 outcomes 106 studies in 1393 results : IBA
  2. Spironolactone (Aldactone) : 17 outcomes 18 studies in 178 results : FDA 38 Generic
  3. Renin : 14 outcomes 45 studies in 677 results : IBA
  4. eplerenone (Inspra) : 5 outcomes 3 studies in 14 results : FDA 3 Generic
  5. Potassium : 4 outcomes 13 studies in 216 results : IBA
  6. Sodium : 4 outcomes 11 studies in 218 results : IBA
  7. Dexamethasone (Maxidex) : 4 outcomes 8 studies in 112 results : FDA 77 Generic
  8. Amiloride (Midamor) : 4 outcomes 3 studies in 30 results : FDA 11 Generic
  9. Enalapril : 4 outcomes 3 studies in 8 results : FDA 28 Generic
  10. Mineralocorticoid Receptors (Mineralocorticoid Receptor) : 4 outcomes 2 studies in 71 results : IBA
Show All >>

Diseases Related to Hyperaldosteronism

  1. Hypertension (High Blood Pressure)
  2. Adenoma (Adenomas)
  3. Hyperplasia
  4. Hypokalemia
  5. Cushing Syndrome
Show All >>

Key Therapies for Hyperaldosteronism

Efficacy Chart >>
  1. Adrenalectomy : 37 outcomes 26 studies in 300 results
  2. Oral Administration : 2 outcomes in 5 results
  3. Drug Therapy (Chemotherapy) : 1 outcome in 9 results
  4. Aftercare (After-Treatment) : 4 studies in 26 results
  5. Sodium-Restricted Diet (Diet, Sodium Restricted) : 2 studies in 10 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.